Lead the trend of aesthetic medicine and enjoy the longevity of your beauty and youth.
The global average annual output value of Aesthetic Medicine market is
NTD 162 billion.
The research of American Medical Insight Inc. indicates that
the average annual output value of global Aesthetic Medicine market is NTD 162 billion,
in which Taiwan is one of the fastest growing market in Asia.
This means that Taiwan is a highly active market.
Lyra Co. specifically focuses on the beauty business as a unit of Shaw Han Biomedical Group. Lyra Co. has built solid relationships with American Implantech, Italian Quanta System, German Human Med, Korean Viol, Choyang, Dutsch Humeca, and UK Avita to introduce a variety of products and equipment which includes Laser, IPL, face lifting, WAL, Autologous fat transplantation, facial implant, dermatome for chin and burns, Gauzes, and autologous cell suspension spray.
Lyra Co. is focusing on developing artificial cartilage composite materials specifically for Asians with American companies and is acquiring numerous patents to create a potentially new age of the facial implantation market.
